Establishment of a low-tumorigenic MDCK cell line and study of differential molecular networks

Gui-Lan Ma1, Zi-Lin Qiao2, Dan He2

  • 1College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, 730030, PR China; Gansu Tech Innovation Center of Animal Cell, Biomedical Research Center, Northwest Minzu University, Lanzhou, 730030, PR China.

Insights

New low-tumorigenic Madin-Darby canine kidney (MDCK) cell lines were developed for influenza vaccine production. These cell lines show reduced tumorigenicity and high proliferation rates, addressing key concerns in vaccine manufacturing.

Area of Science:

  • Biotechnology
  • Virology
  • Cell Biology

Background:

  • Influenza virus is a significant respiratory pathogen.
  • Vaccination is the primary method for influenza prevention.
  • Madin-Darby canine kidney (MDCK) cells are crucial for influenza virus isolation but have high tumorigenicity concerns for vaccine production.

Purpose of the Study:

  • To establish and characterize novel, low-tumorigenic MDCK cell lines.
  • To investigate the molecular mechanisms underlying tumorigenicity and proliferation in MDCK cells.

Main Methods:

  • Development of monoclonal cell lines MDCK-C09 and MDCK-C35.
  • RNA sequencing (RNA-seq) of MDCK-C09, MDCK-C35, and MDCK-W73 cells.
  • Bioinformatic analysis of differentially expressed genes and molecular interactions.

Main Results:

  • MDCK-C09 and MDCK-C35 cell lines exhibited significantly lower tumorigenicity.
  • RNA-seq identified key genes (e.g., CUL3, EGFR) potentially involved in tumorigenicity differences.
  • Downregulation of JUN and MYC was associated with increased cell proliferation.

Conclusions:

  • Novel low-tumorigenic MDCK cell lines (MDCK-C09, MDCK-C35) have been successfully established.
  • Potential molecular mechanisms for reduced tumorigenicity and enhanced proliferation have been elucidated.
  • These findings offer a promising alternative for safer influenza vaccine production.

Related Concept Videos